What did Coloplast pay for Kerecis?

Coloplast acquired Kerecis for $1.30B in 2023, equivalent to 17.40x revenue. Target revenue was approximately $74.7M.

What does Kerecis do?

Kerecis is a medical devices business.

What multiple did Coloplast pay for Kerecis?

17.40x revenue, based on disclosed deal value of $1.30B and disclosed financials.

M&A TRANSACTION · 2023

Kerecis acquired by Coloplast

$1.30B· 17.40x revenue

Target

Kerecis

Acquirer

Coloplast

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$74.7M

EBITDA

—

Deal Value

$1.30B

EV/EBITDA

—

Context

This $1.30B acquisition of Kerecis by Coloplast sits in the medical devices sub-vertical. Coloplast is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.

Source

Data sourced from Press release. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Kerecis acquisition.

Citation: ExitValue.ai. (2023). Kerecis acquired by Coloplast. https://exitvalue.ai/deals/kerecis-acquired-by-coloplast-hc-2023-0044